Have a requirement?
Chat with us
Have a requirement?
Chat with us
- Pemetrexed For Injection (Pemexam-500) 500 MG
- L Asparaginase Injection ( L-Aparagin )10000 IU
- Pegaspargase Injection (Peg- Aparagin) 3750 IU/5 ML
- Melphalan For Injection (Dufalan) 50MG
- Liposomal Amphotericin B Injection ( Anolip) 50 MG
- Menotropin Injection ( Eugon XP) 1200 IU/ 2 ML
- Pemetrexed For Injection (Pemexam-100) 100 MG
- Docetaxel Injection (Docet) 120 MG/ 3 ML
- Docetaxel Injection (Docet) 80 MG /2 ML
- Docetaxel for Injection (Docet) 20 MG/0.5 ML
- Zoledronic Acid For Injection (Zunitra) 4MG/5ML
- Paclitaxel Injection (Paclicell) 260 MG/43.40 ML
- Doxorubicin HCL For Injection (Doxorex-50) 50 MG
- Amphotericin B for Injection ( Amphodex) 50 MG
- Calcium Folinate Injection (Leucorin) 15 MG/2 ML
- Ondansetron Injection (ONO) 8 MG/4ML
- Paclitaxel Injection (Paclicell)100 MG/16.7 ML
- Paclitaxel Injection (Paclicell) 30 MG/5 ML
- Ondansetron Injection (ONO) 4mg/2ml
- Doxorubicin HCL For Injection( Doxorex-10)10 MG
- Calcium Folinate Injection (Leucovorin) 50 MG / 5ML
- Plerixafor Injection ( Rexafor ) 20 MG
- Doxorubicin Hcl For Injection( Adriplus 50) 50mg
- Paclitaxel For Injectable Suspension ( Nab Dutaxel)100 MG
- Doxorubicin HCL Injection ( Doxorex PL) 2 MG/ML,10 ML
- Gemcitabine Injection (Lifogem) 1 GM
- Fulvestrant Injection (Fulveser)5 ML
- Bortezomib for Injection (Bortesam) 2 MG
- Oxaliplatin For Injection (Oxoplan- 50)50 MG/10ML
- Degarelix For Injection(Samgalix) 80 MG
- Megestrol Acetate Oral Suspension (Endace OS)40 Mg/Ml
- Megestrol Acetate Oral Suspension (Endace OS) 40 MG/ML
- Oxaliplatin For Injection( Oxoplan-100) 100 MG
- Degarelix For Injection (Samgalix) 120 MG
- Thiotepa For Injection (Samtepa) 15 MG
- Thiotepa For Injection (Samtepa) 100 MG
- Carboxymethyl Cellulose Eye Drops (Lacrivisc) 0.5 %, 10 ML
- Moxifloxacin Eye Drops (Moximoxi) 5 ML
- Sodium Hyaluronate 3 % w/v with Sodium Chondroitin Sulphate 4 % w/v Ophtalmic Solution,(Phacovisc)
- Moxifloxacin 0.5% & Loterednol Etabonate Ophtalmic 0.5 %, (Moximoxi-LP) 5ML
- Polymyxin B Sulfate, Chloramphenicol & Dexamethasone Sodium Phosphate Eye Ointment (Polysporin Dexa)
- +8 more products
Oncology Injection
| Dosage Form | Injection |
| Strength | 500 mg |
| Treatment | Combination Therapy |
| Brand Name | PEMAXAM-500 |
| Form | Injection |
| Pharmacopoeia Standard | IP |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
| Brand | PEMEXAM 500 |
| Generic Name | Pemetrexed Injection |
| Packaging Size | 1 vial |
| Manufactured By | Samarth Life Sciences Pvt Ltd. |
Product Name: Pemetrexed Injection 500 MG
Brand Name: Pemaxam-500
Strength: 500 MG
Packing: Vial
Pemetrexed for Injection, manufactured by Samarth Pharma, is a medication used in cancer treatment. It belongs to the class of drugs known as antifolates and works by inhibiting the enzymes involved in DNA and RNA synthesis, thereby preventing the growth and spread of cancer cells. Pemetrexed is indicated for the treatment of various types of cancer, including lung cancer and mesothelioma. It is typically administered intravenously under medical supervision.
View Complete Details
L Asparaginase Injection ( L-Aparagin )10000 IU
₹ 101/PieceGet Latest Price
Minimum Order Quantity: 100 Piece
| Strength | 10000 KU |
| Brand | L-APARAGIN |
| Packaging Type | Vial |
| Manufacturer | SAMARTH LIFE SCIENCE PVT. LTD |
| Storage Temperature | 20-25 degree c |
| Shelf Life | 18 months |
| Country of Origin | Made in India |
Product Name: L Asparaginase Injection 10000 IU
Brand Name: L-Aparagin
Strength: 10000 IU
Packing: Single Vial Per Box
-
Description:
- L Asparaginase is an enzyme used in cancer treatment to inhibit protein synthesis by depleting asparagine, particularly in leukemic cells.
- It is administered as an injection.
-
Mechanism of Action:
- L Asparaginase catalyzes the hydrolysis of asparagine to aspartic acid and ammonia, depriving leukemic cells of asparagine, an essential amino acid, thereby inhibiting their growth.
-
Indications:
- Used in the treatment of acute lymphoblastic leukemia (ALL) as part of combination chemotherapy regimens.
-
Administration:
- Administered intravenously or intramuscularly by a healthcare professional.
- Dosage and frequency depend on the patient's weight, age, and overall health, as well as the specific chemotherapy regimen being followed.
-
Adverse Reactions:
- Common side effects include nausea, vomiting, fever, allergic reactions, and liver toxicity.
- Pancreatitis, coagulopathy, and central nervous system toxicity are rare but severe adverse effects that may occur.
-
Contraindications:
- Hypersensitivity to L asparaginase or any of its components.
- Previous severe allergic reactions to L asparaginase.
- Severe liver or pancreatic disease.
-
Precautions:
- Monitor liver function tests regularly during treatment to detect and manage hepatic toxicity.
- Administer with caution in patients with a history of pancreatitis or coagulopathy.
-
Drug Interactions:
- Concurrent use with hepatotoxic drugs may increase the risk of liver toxicity.
- Avoid concomitant use with other potentially myelosuppressive agents whenever possible.
-
Storage:
- Store L asparaginase vials at controlled room temperature (20-25°C).
- Protect from light and moisture.
- Do not freeze.
-
Availability:
- L Asparaginase is available in various strengths, typically supplied in single-dose vials for parenteral administration.
-
Monitoring and Follow-Up:
- Monitor for signs of treatment response, disease progression, and adverse reactions throughout the course of therapy.
- Adjust dosage or treatment schedule as necessary based on patient response and tolerability.
-
Emergency Management:
- Be prepared to manage potential severe adverse effects such as pancreatitis, coagulopathy, or allergic reactions promptly and effectively.
- Ensure healthcare providers administering L asparaginase are trained in oncology and chemotherapy management.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Pegaspargase Injection (Peg- Aparagin) 3750 IU/5 ML
₹ 1,689/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 3750 IU / 5 ml |
| Packaging Size | 5 ml |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| Manufactured By | Samarth Life Science Pvt Ltd |
| Brand Name | PEG-APARAGIN |
Product Name: Pegaspargase Injection
Brand Name: PEG-APARAGIN
Strength: 3750 IU/ 5 ML(750 IU/ML)
Packing: Single Vial Per Box
Mechanism of Action: It works by breaking down a specific amino acid called asparagine in the body, which is necessary for the growth and survival of cancer cells.
Formulation: Available as a sterile, clear, colorless to slightly yellow solution for intramuscular or intravenous injection.
Dosage: Administered under the supervision of a healthcare professional as per the prescribed dosage and schedule.
Frequency: Usually given every few weeks, depending on the treatment plan and individual patient response.
Adverse Effects: Possible side effects include nausea, vomiting, fever, allergic reactions, liver problems, and blood clotting disorders.
Precautions: Patients should be monitored for signs of allergic reactions, liver function, and blood clotting abnormalities during treatment.
Contraindications: Not recommended for individuals with a history of severe allergic reactions to pegaspargase or other asparaginase formulations.
Storage: Store at controlled room temperature, away from light and moisture.
Availability: Typically prescribed in hospital or clinical settings, administered by healthcare professionals trained in chemotherapy administration.
Follow-Up: Regular follow-up appointments are essential to monitor treatment response and manage any potential side effects.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 12-15 days
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Melphalan For Injection (Dufalan) 50MG
₹ 201/BottleGet Latest Price
Minimum Order Quantity: 100 Bottle
| Strength | 50mg |
| Form | Injection |
| Country of Origin | Made in India |
| Brand | DUFALAN |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
Product Name: Melphalan For Injection
Brand Name: Dufalan
Strength: 50 MG
Packing: Single Vial Per Box
- Melphalan For Injection is a chemotherapy medication used to treat various types of cancer, including multiple myeloma and ovarian cancer.
- It belongs to the class of alkylating agents and works by interfering with the DNA replication process in cancer cells, ultimately leading to their death.
- This injection form of melphalan is typically administered intravenously under the supervision of healthcare professionals.
- Melphalan is often used as part of combination chemotherapy regimens or as a conditioning treatment before stem cell transplantation.
- Dosage and administration of melphalan should be carefully tailored to each patient's condition, considering factors such as weight, age, and overall health.
- Common side effects may include bone marrow suppression, nausea, vomiting, and hair loss.
- Melphalan For Injection is an important treatment option in cancer care, playing a crucial role in fighting and managing various malignancies.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 WEEKS
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Liposomal Amphotericin B Injection ( Anolip) 50 MG
₹ 301/PieceGet Latest Price
Minimum Order Quantity: 100 Piece
| Formulation Type | Liposomal |
| Dosage/Strength | 50 mg |
| Strength | 50 mg vial |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
| Brand | ANOLIP |
| Injection Type | Lyophilized powder |
| Packaging Type | Vial with carton |
| Shelf Life | 18 months |
| Packaging Size | 10ml |
| Form | Injection |
| Dosage Strength | 50mg/10ml |
| Country of Origin | Made in India |
Product Name: Liposomal Amphotericin B Injection
Brand Name: Anolip
Strength: 50 MG/ 10 ML
Packing: Single Vial Per Box
-
Description:
- Amphotericin B lipid complex is a formulation of the antifungal medication amphotericin B.
- It is composed of amphotericin B complexed with lipid molecules to improve solubility and reduce toxicity.
- It is available for intravenous administration.
-
Mechanism of Action:
- Amphotericin B acts by binding to ergosterol, a component of fungal cell membranes, leading to disruption of membrane integrity and fungal cell death.
-
Indications:
- Treatment of invasive fungal infections, including candidemia, invasive aspergillosis, cryptococcal meningitis, and mucormycosis, particularly in patients who are refractory to or intolerant of other antifungal agents.
-
Administration:
- Administered intravenously over a specified period, typically once daily.
- Dosage and duration of treatment depend on the type and severity of the fungal infection, as well as the patient's overall health status.
-
Adverse Reactions:
- Common side effects include fever, chills, nausea, vomiting, and headache.
- Infusion-related reactions, such as hypotension, tachycardia, and dyspnea, may occur during or shortly after administration.
- Nephrotoxicity and electrolyte abnormalities are potential serious adverse effects that may occur with prolonged use.
-
Contraindications:
- Hypersensitivity to amphotericin B or any of its components.
- Pre-existing severe renal impairment.
- Pregnancy or breastfeeding due to potential harm to the fetus or infant.
-
Precautions:
- Monitor renal function, electrolyte levels, and vital signs regularly during treatment.
- Use with caution in patients with pre-existing renal impairment, electrolyte abnormalities, or cardiac disease.
-
Drug Interactions:
- Amphotericin B may interact with other medications that are nephrotoxic or affect renal function, potentially increasing the risk of kidney damage.
- Avoid concomitant use with nephrotoxic drugs whenever possible.
-
Storage:
- Store amphotericin B lipid complex vials at controlled room temperature (20-25°C).
- Protect from light and moisture.
- Do not freeze.
-
Availability:
- Amphotericin B lipid complex is available in single-dose vials containing a specified strength of the medication.
-
Monitoring and Follow-Up:
- Monitor for signs of treatment response, disease progression, and adverse reactions throughout the course of therapy.
- Adjust dosage or treatment schedule as necessary based on patient response and tolerability.
-
Emergency Management:
- Be prepared to manage potential severe adverse effects such as infusion-related reactions or nephrotoxicity promptly and effectively.
- Ensure healthcare providers administering amphotericin B lipid complex are trained in infectious diseases management and antifungal therapy.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 WEEKS
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Menotropin Injection ( Eugon XP) 1200 IU/ 2 ML
₹ 405/PieceGet Latest Price
| Strength | 1200 IU/ 2 ML |
| Brand Name | EUGON XP – 1200 |
| Form | Injection |
| Packaging Type | Vial |
| Manufacturer | Samarth Life Sciences |
| Purity | Highly Purified (HP) |
| Dose Strength | 1200 IU/ 2 ML |
| Product Type | API |
| Manufactured By | Samarth Life Science Pvt. Ltd |
| Country of Origin | Made in India |
Product Name: Menotropin Injection
Brand Name: Eugon XP
Strength: 1200 IU/ 2 ML
Packing: Multidose Vial Per Box
Mechanism of Action
- Mimics natural FSH and LH in the body
- FSH: Promotes growth and maturation of ovarian follicles in women; stimulates spermatogenesis in men
- LH: Triggers ovulation and formation of the corpus luteum in women; stimulates testosterone production in men
- Female Infertility:
- Induces ovulation in women with anovulation or oligo-ovulation
- Used in assisted reproductive technologies (ART) such as in vitro fertilization (IVF)
- Male Infertility:
- Stimulates spermatogenesis in men with hypogonadotropic hypogonadism
- Typical Dosage: Individualized based on response and treatment protocol
- Administration: Subcutaneous or intramuscular injection
- Frequency: Often daily, typically starting on the second or third day of the menstrual cycle in women.
Additional Information:
- Packaging Details: Multidose Vial Per Box
View Complete Details
Pemetrexed For Injection (Pemexam-100) 100 MG
₹ 150/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Dosage Form | Injection |
| Strength | 100mg |
| Treatment | Combination Therapy |
| Pack Type | Vial |
| Brand Name | PEMAXAM-100 |
| Form | Injection |
| Pharmacopoeia Standard | IP |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
| Packing | 1 Vial |
| Brand | PEMAXAM-100 |
| Generic Name | Pemetrexed Injection |
| Manufactured By | Samarth Life Sciences Pvt Ltd. |
Product Name: Pemetrexed Injection IP 100 MG
Brand Name: Pemaxam
Strength: 100 MG
Packing: Single Vial Per Box
- Name: Pemetrexed Injection IP 100 mg
- Purpose: Chemotherapy treatment for certain types of cancer, including lung cancer and mesothelioma.
- Active Ingredient: Pemetrexed.
- Dosage Strength: Each vial contains 100 mg of pemetrexed.
- Dosage Form: Solution for intravenous administration.
- Mechanism of Action: Inhibits enzymes involved in DNA synthesis and cell replication, thereby slowing cancer growth.
- Indications: Effective in treating non-small cell lung cancer and mesothelioma.
- Contraindications: Hypersensitivity to pemetrexed or its components, severe renal impairment.
- Adverse Reactions: Common side effects include fatigue, nausea, vomiting, and bone marrow suppression; may also cause rash and diarrhea.
- Storage: Store at room temperature, protect from light.
- Prescription: Administered by oncologists or experienced healthcare professionals.
- Counseling: Educate patients on potential side effects and the importance of hydration during treatment.
- Pregnancy/Lactation: Avoid during pregnancy and breastfeeding; discuss risks with healthcare provider.
- Interactions: Check for potential interactions with other medications, especially those affecting kidney function or folate metabolism.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
| Formulation Type | Solution |
| Form of Medicine | Lyophilized |
| Brand | DOCET |
| Strength | 120 mg |
| Pack Size | 3 ml |
| Pack Type | Vial |
| Indication | Breast Cancer |
| Packaging Size | 3 ml |
| Brand Name | DOCET |
| Manufacturer | Samarth Lifesciences |
| Country of Origin | Made in India |
Product Name: Docetaxel Injection
Brand Name: Docet
Strength: 120 MG/ 3 ML
Packing: Single Vial Per Box
Docet is designed for precision, reliability, and patient safety. It provides oncologists with a dependable option in cancer management, supporting patients through their treatment journey with confidence.
Key Features:
• Clinically proven efficacy across multiple cancer types
• High-quality, solvent-based formulation ensuring potency and stability
• Manufactured under strict GMP standards to maintain global quality benchmarks
• Secure packaging to preserve integrity until administration
• Supported by Genex Pharma’s vision of delivering life-saving oncology solutions worldwide
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
Docetaxel Injection (Docet) 80 MG /2 ML
₹ 1,001/VialGet Latest Price
| Formulation Type | Solution |
| Form of Medicine | Lyophilized |
| Brand | DOCET |
| Pack Size | 2 ml |
| Strength | 80mg |
| Pack Type | Vial |
| Indication | Breast Cancer |
| Form | Injection |
| Packaging Size | Single vial per box |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
Product Name: Docetaxel Injection
Brand Name: Docet
Strength: 80 mg/2ml
Packing: Single Vial Per Box
💊 Key Highlights:
• High-quality formulation ensuring safety and efficacy
• Packaged as a single vial per box for convenient administration
• Manufactured under stringent GMP standards to meet global healthcare needs
• Backed by Genex Pharma’s commitment to quality, trust, and innovation in oncology care
View Complete Details
Docetaxel for Injection (Docet) 20 MG/0.5 ML
₹ 200/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Formulation Type | Solution |
| Form of Medicine | Lyophilized |
| Brand | DOCET |
| Strength | 20 mg |
| Pack Size | 0.5 ml |
| Pack Type | Vial |
| Indication | Breast Cancer |
| Packaging Size | 0.5 ml |
| Brand Name | Docet |
| Manufacturer | Samarth Life Science Pvt. Ltd |
| Country of Origin | Made in India |
Docetaxel Injection (DOCET 20 mg / 0.5 mL)
- Brand Name: DOCET
- Composition: Docetaxel 20 mg / 0.5 mL
- Form: Injectable (Single-use vial)
- Therapeutic Use: Chemotherapy agent used for the treatment of various cancers
- Mechanism of Action: Docetaxel inhibits the mitotic spindle formation, disrupting cell division and leading to the death of cancer cells.
- Indications:
- Treatment of breast cancer
- Non-small cell lung cancer (NSCLC)
- Prostate cancer
- Ovarian cancer
- Head and neck cancer
- Dosage: Administered intravenously as prescribed by the oncologist, typically every 3 weeks depending on the type and stage of cancer.
- Packaging: Single vial of 20 mg / 0.5 mL per box
- Shelf Life: 24 months from manufacturing date
- Storage Conditions: Store below 25°C, protect from light.
- Key Features:
- Proven efficacy in multiple cancer types
- Widely used in chemotherapy regimens
- High-quality formulation for targeted treatment
Additional Information:
- Production Capacity: 1000
- Delivery Time: 3-4 Weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
Zoledronic Acid For Injection (Zunitra) 4MG/5ML
₹ 195/PieceGet Latest Price
Minimum Order Quantity: 100 Piece
| Dose/Strength | 4 MG/5 ML |
| Packaging Type | Vial |
| Strength | 4MG /5 ML |
| Brand | ZUNITRA |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
Product Name: Zoledronic Acid For Injection
Brand Name: Zunitra
Strength: 4 MG/ 5 ML
Packing: A Single Vial Per Box
Product Description
ZUNITRA (Zoledronic Acid for Injection 4 mg/5 mL), manufactured by Genex Pharma, is a potent bisphosphonate used for the management of bone-related complications in cancer patients. Zoledronic Acid is a third-generation nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption, reducing skeletal-related events such as fractures, bone pain, and hypercalcemia.
Indications
ZUNITRA is indicated for the treatment of:
Hypercalcemia of Malignancy (HCM) – elevated calcium levels due to cancer.
Multiple Myeloma – for prevention of skeletal-related events.
Bone Metastases from Solid Tumors (e.g., breast, prostate, lung cancers) – to reduce fracture risk and bone complications.
Osteoporosis (in specific clinical settings, as prescribed).
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Paclitaxel Injection (Paclicell) 260 MG/43.40 ML
₹ 201/VialGet Latest Price
| Formulation Type | Conventional |
| Brand | PACLICELL |
| Pharmacopoeia Standard | IP |
| Strength | 260 mg |
| Pack Size | 43.4 ml |
| Pack Type | Vial |
| Packaging Size | 43.4 ml |
| Shelf Life | 36 months |
| Brand Name | PACLICELL |
| Country of Origin | Made in India |
Product Name: Paclitaxel Injection IP 260 MG
Brand Name: Paclicell
Strength: 260 MG/ 43.40 ML
Packing:Single Vial Per Box
- Name: Paclitaxel Injection IP 260 mg
- Purpose: Used in chemotherapy to treat various cancers, including breast, ovarian, and lung cancers.
- Active Ingredient: Paclitaxel.
- Dosage Strength: Each vial contains 260 mg of paclitaxel.
- Dosage Form: Solution for intravenous administration.
- Mechanism of Action: Inhibits cancer cell growth by stabilizing microtubules, disrupting cell division.
- Indications: Effective against metastatic breast cancer, advanced ovarian cancer, and non-small cell lung cancer.
- Contraindications: Hypersensitivity to paclitaxel or its components.
- Adverse Reactions: Common side effects include hair loss, nausea, vomiting, and neuropathy; may also cause bone marrow suppression and allergic reactions.
- Storage: Store at room temperature, protect from light.
- Prescription: Administered by oncologists or experienced healthcare professionals.
- Counseling: Educate patients on potential side effects and the need for close monitoring during treatment.
- Pregnancy/Lactation: Avoid during pregnancy and breastfeeding; discuss risks with healthcare provider.
- Interactions: Check for potential interactions with other medications, especially those metabolized by CYP2C8 and CYP3A4 enzymes.
Additional Information:
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Doxorubicin HCL For Injection (Doxorex-50) 50 MG
₹ 1,250/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 50 mg |
| Formulation Type | Micellar |
| Form Of Medicine | Lyophilized |
| Pack Type | Vial |
| Brand | DOXOREX-10 |
| Manufacturer | samarth life science Pvt. Ltd |
| Storage Condition | Protected from Light |
| Brand Name | Doxorex-50 |
| Pharmacopoeia Standard | IP |
| Packaging Size | 1 ml |
| Country of Origin | Made in India |
Product Name: Doxourubicin HCL For Injection
Brand Name: Doxorex
Strength: 50 MG
Packing: Single Vial Per Box
Doxorubicin HCl for injection is a chemotherapy medication used to treat various types of cancer. Here's a concise description with pointers:
-
Purpose: Doxorubicin HCl is utilized in cancer treatment to inhibit the growth and spread of cancer cells.
-
Administration: Administered intravenously by healthcare professionals in a hospital or clinical setting.
-
Mechanism of Action: Doxorubicin disrupts DNA replication and RNA transcription in cancer cells, leading to cell death.
-
Indications: Used in the treatment of various cancers, including breast cancer, lung cancer, ovarian cancer, and certain types of leukemia and lymphoma.
-
Dosage: Dosage is determined based on factors such as the type of cancer, body weight, and overall health of the patient.
-
Side Effects: Common side effects may include nausea, vomiting, hair loss, fatigue, and increased susceptibility to infections. Cardiotoxicity is a significant concern with doxorubicin use.
-
Contraindications: Avoid use in patients with preexisting heart conditions, severe bone marrow suppression, or known hypersensitivity to doxorubicin or other anthracyclines.
-
Precautions: Care should be taken in patients with impaired liver or kidney function, as well as those with preexisting cardiac risk factors.
-
Storage: Store doxorubicin HCl for injection according to manufacturer instructions, typically at controlled room temperature and protected from light.
-
Patient Monitoring: Regular monitoring of blood counts, liver function, and cardiac function is necessary during treatment to detect and manage potential adverse effects.
-
Education: Patients should be educated on the purpose of the medication, potential side effects, and the importance of adherence to the prescribed treatment regimen.
-
Follow-Up: Close follow-up with healthcare providers is essential to monitor treatment response, manage side effects, and adjust the treatment plan as needed.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 Weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Amphotericin B for Injection ( Amphodex) 50 MG
₹ 1,001/VialGet Latest Price
| Formulation Type | Liposomal |
| Dosage/Strength | 50 mg |
| Strength | 50 mg vial |
| Brand | Amphodex |
| Injection Type | Lyophilized powder |
| Packaging Type | Vial with carton |
| Shelf Life | 30 months |
| Packaging Size | Single vial per pack |
| Manufacturer | Samarth Lifesciences |
| Country of Origin | Made in India |
Product Name:Amphotericin B for Injection
Brand Name: Amphodex
Strength: 50 MG
Packing: Single Vial Per Box
Product Description:
AMPHODEX (Amphotericin B for Injection 50 mg), manufactured by Genex Pharma, is a broad-spectrum antifungal medication belonging to the polyene class of antibiotics. It is a well-established therapy for the treatment of severe, life-threatening systemic fungal infections. Amphotericin B acts by binding to ergosterol in fungal cell membranes, causing membrane disruption and leakage of essential cell components, ultimately leading to fungal cell death.
Indication:
AMPHODEX is indicated for the treatment of severe systemic fungal infections, including:
-
Aspergillosis
-
Candidiasis (systemic, invasive)
-
Cryptococcosis (including cryptococcal meningitis)
-
Histoplasmosis
-
Mucormycosis
-
Blastomycosis
-
Coccidioidomycosis
-
Paracoccidioidomycosis
-
Other progressive, potentially life-threatening mycoses unresponsive to conventional therapy
View Complete Details
Calcium Folinate Injection (Leucorin) 15 MG/2 ML
₹ 1,200/PieceGet Latest Price
Minimum Order Quantity: 100 Piece
| Brand | CALCIUM LEUCOVORIN |
| Dose/ Strength | 15 mg/ 2ml |
| Pharmacopoeia Standard | IP |
| Packaging Size | 2ml |
| Packaging Type | Vial |
| Usage/Application | Hospital |
| Dose | 15 mg |
| Concentration | 20 mg/ml |
| Form | Injection |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
Product Name: Leucovorin Calcium Folinate Injection
Brand Name: Leucorin
Strength: 15 MG/ 2 ML
Packing: Single Vial Per Box
Manufacturer: Genex Pharma
Indication: Resue therapy after high dose methotrexate, treatment of folate deficient anemia, and as an adjunct in certain cancer chemotherapy regimens.
Storage: Store at 2°C to 8°C.
Description
Leucorin contains Leucovorin Calcium, the active, reduced form of folic acid. Unlike folic acid, leucovorin does not require enzymatic reduction by dihydrofolate reductase (DHFR) to be active, enabling it to bypass metabolic blockades caused by DHFR inhibitors like methotrexate. It is available as a ready-to-use sterile injection for IV or IM administration.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: Single Vial Per Box
View Complete Details
| Strength | 8 mg/4ml |
| Pack size | 4 ml |
| Brand | ONO |
| Pack type | Ampoule |
| Route | IV IM |
| Prescription | Rx only |
| Packaging | 5 X 4ml |
| Manufacturer | Samarth Life Sciences |
| Packaging Type | Vial |
| Generic Name | Ondansetron Injection |
Product Name:Ondansetron Injection IP 8 MG
Brand Name: ONO
Strength: 8 MG/4 ML
Packing: 5 Ampoules Per Box
Mechanism of Action
Ondansetron is a selective serotonin (5-HT₃) receptor antagonist. It prevents nausea and vomiting by blocking serotonin receptors both:
-
Centrally: in the chemoreceptor trigger zone of the medulla.
-
Peripherally: on vagal nerve terminals in the gastrointestinal tract.
This dual action effectively reduces the reflex pathway responsible for chemotherapy-induced, radiotherapy-induced, and postoperative nausea and vomiting (CINV, RINV, PONV).
Ondansetron Injection (ONO) 8 mg is indicated for:
Prevention and treatment of nausea and vomiting associated with:
Highly or moderately emetogenic cancer chemotherapy.
Radiotherapy (single high-dose fraction, total body irradiation, or daily fractionated therapy).
Postoperative recovery following anesthesia and surgery.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: 5 Ampoules Per Box
View Complete Details
Paclitaxel Injection (Paclicell)100 MG/16.7 ML
₹ 201/VialGet Latest Price
| Formulation Type | Conventional |
| Brand | PACLICELL |
| Pharmacopoeia Standard | IP |
| Strength | 100 mg |
| Pack Size | 16.7 ml |
| Pack Type | Vial |
| Packaging Size | 16.7 ml |
| Shelf Life | 12 months |
| Brand Name | PACLICELL |
| Country of Origin | Made in India |
Product Name: Paclitaxel Injection IP
Brand Name: Paclicell
Strength: 100 MG/ 16.7 ML
Packing: Single Vial Per Box
- Name: Paclitaxel Injection IP 100 mg/16.7 mL
- Purpose: Chemotherapy treatment for various cancers like breast, ovarian, and lung cancers.
- Active Ingredient: Paclitaxel.
- Dosage Strength: Each vial contains 100 mg of paclitaxel in 16.7 mL solution.
- Dosage Form: Solution for intravenous administration.
- Mechanism of Action: Inhibits cancer cell growth by stabilizing microtubules, disrupting cell division.
- Indications: Effective against metastatic breast cancer, advanced ovarian cancer, and non-small cell lung cancer.
- Contraindications: Hypersensitivity to paclitaxel or its components.
- Adverse Reactions: Common side effects include hair loss, nausea, vomiting, and neuropathy; may also cause bone marrow suppression and allergic reactions.
- Storage: Store at room temperature, protect from light.
- Prescription: Administered by oncologists or experienced healthcare professionals.
- Counseling: Educate patients on potential side effects and the need for close monitoring during treatment.
- Pregnancy/Lactation: Avoid during pregnancy and breastfeeding; discuss risks with healthcare provider.
- Interactions: Check for potential interactions with other medications, especially those metabolized by CYP2C8 and CYP3A4 enzymes.
Additional Information:
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Paclitaxel Injection (Paclicell) 30 MG/5 ML
₹ 201/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Formulation Type | Conventional |
| Pharmacopoeia Standard | IP |
| Brand | PACLICELL |
| Pack Size | 5 ml |
| Strength | 30mg / 5ml |
| Pack Type | Vial |
| Packaging Size | 5 ml |
| Form | Injection |
| Shelf Life | 36 months |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
| Brand Name | PACLICELL |
Product Name: Paclitaxel Injection IP 30 MG
Brand Name: Paclicell
strength: 30 MG/ 5 ML
Packing: Single vail per box
- Name: Paclitaxel Injection 30 mg
- Purpose: Used in chemotherapy for various cancers, including breast, ovarian, and lung cancers.
- Active Ingredient: Paclitaxel.
- Dosage Strength: Each vial contains 30 mg of paclitaxel.
- Dosage Form: Solution for intravenous administration.
- Mechanism of Action: Inhibits cancer cell growth by stabilizing microtubules, disrupting cell division.
- Indications: Effective against metastatic breast cancer, advanced ovarian cancer, and non-small cell lung cancer.
- Contraindications: Hypersensitivity to paclitaxel or its components.
- Adverse Reactions: Common side effects include hair loss, nausea, vomiting, and neuropathy; may also cause bone marrow suppression and allergic reactions.
- Storage: Store at room temperature, protect from light.
- Prescription: Administered by oncologists or experienced healthcare professionals.
- Counseling: Educate patients on potential side effects and the need for close monitoring during treatment.
- Pregnancy/Lactation: Avoid during pregnancy and breastfeeding; discuss risks with healthcare provider.
- Interactions: Check for potential interactions with other medications, especially those metabolized by CYP2C8 and CYP3A4 enzymes.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
| Strength | 4 mg/ 2ml |
| Pack size | 2 ml |
| Brand | ONO |
| Pack type | Ampoule |
| Route | IV |
| Prescription | Rx only |
| Packaging | 10 x 2 ml |
| Manufacturer | Samarth Life Sciences |
| Generic Name | Ondansetron Injection |
| Dose Strength | 4 mg |
Product Name:Ondansetron Injection USP
Brand Name: ONO-2 ML
Strength: 4 MG
Packing: 10 Ampoules Per Box
CompositionActive Ingredient: Ondansetron Hydrochloride Dihydrate (equivalent to 4 mg Ondansetron per 2 mL).Excipients: Sodium chloride, citric acid monohydrate, sodium citrate dihydrate, and water for injection.Mechanism of Action
Ondansetron is a highly selective 5-HT₃ receptor antagonist. It blocks serotonin receptors located in the:
-
Peripheral nervous system: On vagal nerve terminals in the gastrointestinal tract.
-
Central nervous system: In the chemoreceptor trigger zone (CTZ) of the medulla.
This dual action prevents nausea and vomiting triggered by chemotherapy, radiotherapy, and surgical anesthesia.
Additional Information:
- Production Capacity: 10000
- Delivery Time: 4-5 weeks
- Packaging Details: 10 AMPOULES PER BOX
View Complete Details
Doxorubicin HCL For Injection( Doxorex-10)10 MG
₹ 101/VialGet Latest Price
Minimum Order Quantity: 1000 Vial
| Strength | 10 mg |
| Formulation Type | Micellar |
| Form Of Medicine | Lyophilized |
| Pack Type | Vial |
| Brand | DOXOREX-10 |
| Manufacturer | Samarth Life Science Pvt Ltd |
| Storage Condition | Protected from Light |
| Brand Name | Doxrex 10 |
| Usages | Used for leukemia, lymphoma, breast, ovarian, bladder, lung, gastric, and other cancers. |
| Country of Origin | Made in India |
Produt Name : Doxorubicin Hydrochloride Injection
Brand Name: Doxorex 10
Strength: 10 mg
Packaging: A Single Vial Per Box
Doxorubicin Hydrochloride for Injection (Lyophilized) is an anthracycline chemotherapy drug used to treat various hematologic malignancies and solid tumors. It works by intercalating DNA, inhibiting topoisomerase II, and generating free radicals, leading to cancer cell apoptosis.
Key Details:
- Composition: Available as lyophilized powder (10 mg, 50 mg per vial).
- Indications: Used for leukemia, lymphoma, breast, ovarian, bladder, lung, gastric, and other cancers.
- Administration: Given via IV infusion; dosage depends on treatment regimen and patient factors.
- Precautions: Major risks include cardiotoxicity, myelosuppression, and extravasation injury; regular monitoring is essential.
- Adverse Effects: Common side effects include nausea, alopecia, fatigue, and mucositis, while severe effects involve heart failure, neutropenia, and liver dysfunction.
- Storage: Keep refrigerated (2°C–8°C), protect from light, and follow hazardous drug disposal guidelines.
Due to its potency and toxicity, careful monitoring and supportive care are critical for safe and effective treatment.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
Calcium Folinate Injection (Leucovorin) 50 MG / 5ML
₹ 1,260/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Brand | Leucovorin |
| Dose/ Strength | 50 mg/5 ml |
| Pharmacopoeia Standard | IP |
| Packaging Size | 5 ml |
| Dose | 50 mg |
| Concentration | 50 mg/ml |
| Packaging Type | Vial |
| Manufactured By | Genex Pharma |
| Usage/Application | Commercial |
| Manufacturer | Samarth |
| Country of Origin | Made in India |
Product Name: Calcium Folinate Injection
Brand Name: Calcium Leucovorin
Strength: 50 MG/ 5 ML
Packing: Single Vial Per Box
Manufacrturer:Genex Pharma
Description Calcium Folinate (Calcium Leucovorin) is the calcium salt of Leucovorin, the active, reduced form of folic acid. Unlike folic acid, it bypasses dihydrofolate reductase (DHFR) inhibition and directly participates in nucleic acid synthesis. This makes it essential in counteracting the toxic effects of folate antagonists like methotrexate, while also serving as a biochemical modulator in cancer therapy.
Indications
-
Rescue therapy after high-dose methotrexate in cancer treatment.
-
Modulation of 5-Fluorouracil activity in advanced colorectal carcinoma.
-
Treatment of folate-deficiency megaloblastic anemia (except pernicious anemia).
-
Antidote for folate antagonist toxicity (e.g., methotrexate, trimethoprim, pyrimethamine).
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
| Dosage Form | Solution for Injection |
| Brand | Rexafor |
| Treatment | Stem Cell Mobilization |
| Packaging Type | Vial |
| Strength | 20 mg/ml |
| Manufacturer | Samarth Life Science |
| Storage Condition | Protect from Light |
| Dose/Strength | 24 mg/1.2 ml |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| How Plerixafor works | Plerixafor is an hematopoeitic stem cell mobilizers. It works by causing certain blood cells to move |
| Plerixafor Uses | Plerixafor is used in Autologous stem cell transplant. It is a procedure in which certain blood cell |
Plerixafor Injection 20 mg
Plerixafor Injection 20 mg is a hematopoietic stem cell mobilizer used in combination with granulocyte-colony stimulating factor (G-CSF) to enhance the mobilization of stem cells into the bloodstream. These stem cells are then collected for autologous transplantation in patients with Non-Hodgkin’s Lymphoma (NHL) or Multiple Myeloma (MM).
| Medicine Brand | REXAFOR |
| Medicine Form | Injection |
| Medicine Name | Plerixafor Injection |
| Medicine Strength | 20 mg / ml (24 mg / 1.2 ml) |
| Packaging Type | Single Dose vial |
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: Single Vial Per Box
View Complete Details
Doxorubicin Hcl For Injection( Adriplus 50) 50mg
₹ 1,000/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 50 mg |
| Pack Type | Vial |
| Manufacturer | Metta Life Sciences Private Limited |
| Form | Injection |
| Brand Name | Adriplus |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
Product Name: Doxorubicin Hcl For Injection 50mg
Brand Name: Adriplus 50
Strength: 50 MG
Packing: A Single Vial Per Box
Manufutured: Metta Life Sciences Private Limited
Doxorubicin Hydrochloride is an anthracycline antibiotic that functions as a potent antineoplastic (chemotherapy) agent. It inhibits DNA synthesis by intercalating into DNA strands, disrupting cellular processes necessary for tumor growth. This medication is widely utilized in the treatment of various cancers.
CompositionEach vial contains:
- Doxorubicin Hydrochloride USP: 50 mg
- Lyophilized powder for reconstitution
Doxorubicin HCl for Injection is indicated for the treatment of:
- Breast cancer
- Ovarian cancer
- Lung cancer (both small cell and non-small cell)
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Hodgkin’s and Non-Hodgkin’s lymphoma
- Sarcomas (soft tissue and bone)
- Gastric carcinoma
- Other solid tumors
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
Paclitaxel For Injectable Suspension ( Nab Dutaxel)100 MG
₹ 154/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Formulation Type | Conventional |
| Brand | NAB DUTAXEL |
| Pharmacopoeia Standard | USP |
| Strength | 100 mg |
| Pack Type | Vial |
| Packaging Size | 100 mg |
| Shelf Life | 36 months |
| Brand Name | Nab Dutaxel |
| Manufacturer | Samarath Life Science Pvt. ltd. |
| Country of Origin | Made in India |
Product Name: Paclitaxel (Protein Bound Particles) for Injectable Suspension
Brand Name: Nab Dutaxel
Strength: 100mg
Packing: Single Vial Per Box
Product Description:
Paclitaxel (Protein Bound Particles) for Injectable Suspension, manufactured by Genex Pharma, is a novel formulation of paclitaxel where the drug is bound to human albumin nanoparticles. This solvent-free formulation eliminates the need for conventional solvents like Cremophor® EL, thereby reducing the risk of hypersensitivity reactions and avoiding the need for steroid or antihistamine premedication.
Indications
Paclitaxel (Protein Bound Particles) for Injectable Suspension is indicated for:
Metastatic Breast Cancer (MBC): Especially after failure of combination chemotherapy or relapse within 6 months of adjuvant therapy.
Non-Small Cell Lung Cancer (NSCLC): In combination with carboplatin for patients not suitable for curative surgery or radiation therapy.
Adenocarcinoma of the Pancreas: In combination with gemcitabine for metastatic disease.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
Doxorubicin HCL Injection ( Doxorex PL) 2 MG/ML,10 ML
₹ 1,057/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 2 MG/ML,10 ML |
| Formulation Type | Liposomal |
| Form Of Medicine | Lyophilized |
| Pack Type | Vial |
| Manufacturer | Samarth Life Science Pvt. Ltd |
| Brand Name | Doxorex |
| Country of Origin | Made in India |
Product Name:Doxorubicin Hydrochloride Injection
Brand Name: Doxorex PL
Strength: 2 MG/ ML, 10ML
Packing: Single Vial Per Box
Doxorex PL (Doxorubicin Hydrochloride Injection) is a widely used anthracycline antineoplastic agent with proven efficacy in the treatment of various cancers. It is indicated for breast cancer, ovarian cancer, bladder cancer, gastric cancer, thyroid cancer, small cell and non-small cell lung cancers, as well as hematological malignancies such as leukemias and lymphomas.
Doxorubicin works by intercalating into DNA and inhibiting the enzyme topoisomerase II, leading to the disruption of DNA replication and transcription. Additionally, it generates free radicals that cause irreversible damage to cancer cell DNA, ultimately leading to cell death.
Key Features:
• Broad-spectrum anticancer efficacy across solid tumors and blood cancers
• High-quality formulation ensuring stability, safety, and potency
• Manufactured under stringent GMP-certified facilities meeting global standards
• Ready-to-use solution packaged in a secure vial for ease of administration
• Supported by Genex Pharma’s dedication to oncology innovation and patient safety
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
| Dose/Strength | 1 GM |
| Injection Type | Concentrate |
| Strength | 1GM |
| Composition | Gemcitabine IP |
| Route | IV |
| Brand | LIFOGEM |
| Packaging Size | 1 vial |
| Manufacturer | Samarth Life Sciences Pvt Ltd. |
| Form | Injection |
Product Name: Gemcitabine Injection IP
Brand Name: Lifogem
Stregth: 1GM
Packing: Single Vial Per Box
Lifogem (Gemcitabine Injection) is a pyrimidine antimetabolite chemotherapy medicine widely used in the treatment of several solid tumors. It is indicated for cancers such as pancreatic cancer, non-small cell lung cancer (NSCLC), breast cancer, ovarian cancer, and bladder cancer.
Gemcitabine works by incorporating into DNA strands during replication, leading to inhibition of DNA synthesis and ultimately causing programmed cancer cell death. Its proven clinical efficacy and manageable safety profile make it an essential option in oncology treatment protocols worldwide.
Key Features:
• Broad-spectrum efficacy against multiple cancers
• Reliable formulation ensuring potency, purity, and stability
• Manufactured under strict GMP-certified facilities meeting international quality standards
• Secure packaging to maintain integrity until administration
• Backed by Genex Pharma’s commitment to quality oncology solutions
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 WEEKS
- Packaging Details: A Single Vial Per Box
View Complete Details
| Strength | 250 mg |
| Packaging Type | Vial |
| Volume | 5 ml |
| Packing | SINGLE PFS PER BOX |
| Physical Form | Solution |
| Brand | Fulveser |
| Treatment | Advanced Breast Cancer |
| Manufactured By | Samarth Life Science Pvt Ltd |
| Country of Origin | Made in India |
| Brand Name | Fulveser |
Product Name: Fulvestrant Injection 5 ML
Brand Name: Fulveser
Strength: 250 MG/ 5 ML
Packing: Single PFS Per Box
Fulvestrant injection, available in 5 mL vials, is a medication primarily used to treat hormone receptor-positive metastatic breast cancer. Here's a brief description with pointers:
-
Purpose: Fulvestrant is utilized for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women who have not responded to other hormone therapies.
-
Administration: Administered via intramuscular injection by healthcare professionals in a clinical setting.
-
Mechanism of Action: Fulvestrant is a selective estrogen receptor degrader (SERD) that binds to and blocks estrogen receptors, inhibiting estrogen signaling and slowing cancer growth.
-
Indications: Used as a monotherapy or in combination with other treatments for hormone receptor-positive metastatic breast cancer.
-
Dosage: The standard dosage is 500 mg administered as two 5 mL injections on days 1, 15, and 29, followed by monthly maintenance doses.
-
Side Effects: Common side effects may include injection site reactions, hot flashes, nausea, fatigue, and musculoskeletal pain. Rarely, allergic reactions or liver toxicity may occur.
-
Contraindications: Avoid use in patients with a known hypersensitivity to fulvestrant or any components of the formulation.
-
Precautions: Fulvestrant should be used cautiously in patients with liver impairment, as it may cause hepatotoxicity. Regular liver function tests are recommended during treatment.
-
Storage: Store fulvestrant injection vials according to manufacturer instructions, typically at controlled room temperature and protected from light.
-
Patient Monitoring: Regular monitoring of liver function, blood counts, and disease progression is necessary during treatment to assess for potential adverse effects and treatment response.
-
Education: Patients should be educated on the purpose of the medication, potential side effects, and the importance of adherence to the prescribed dosage regimen.
-
Follow-Up: Close follow-up with healthcare providers is essential to monitor treatment response, manage side effects, and adjust the treatment plan as needed.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE PFS PER BOX
View Complete Details
Bortezomib for Injection (Bortesam) 2 MG
₹ 1,249/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 2 mg |
| Dose/Strength | 2 mg |
| Brand | BORTESAM |
| Pack Size | Vial |
| Form | Lyophilized |
| Route | IV |
| Usage | Lymphoma |
| Packaging Type | Vial |
| Manufactured By | Samarth Life Sciences Pvt. Ltd |
| Packaging Size | Single vial pr box |
| Country of Origin | Made in India |
| Brand name | BORTESAM |
Product Name: Bortezomib for Injection
Brand Name: Bortesam
Strength:2 MG
Packing: A Single Vial Per Box
Bortezomib for Injection is a potent medication used to treat multiple myeloma and mantle cell lymphoma. Administered via injection, it inhibits the growth of cancer cells by blocking certain enzymes, offering hope and improved outcomes for patients battling these conditions.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 Weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
Oxaliplatin For Injection (Oxoplan- 50)50 MG/10ML
₹ 101/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 50 mg |
| Dose/Strength | 50 mg /10 ml |
| Vial Volume | 50 ml |
| Company | Samarth Life Science Pvt Ltd |
| Form | Solution |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Manufacturer | Samarth Life Science Pvt. Ltd |
| Usage/Application | Hospital |
| Packing | Single Vial Per Box |
| Product Name | Oxaliplation For Injection |
Product Name: Oxaliplation For Injection
Brand Name: Oxoplan- 50
Strength: 50 MG
Packing: Single Vial Per Box
Oxaliplatin Injection Lyophilized 50 mg/25 ml, 100mg/50ml (Anti Cancer Injectables)
Oxaliplatin (Anti Cancer Injectables) is a chemotherapy drug that contains platinum. Oxaplantin is indiacted in the treatment of Metastatic clorectal cancer after failure of tretment with fluoropyrimidines alone by monochemotherapy or along with fluoropyrimidines
Indication
-
Oxoplan is used to treat advanced cancer of the colon and rectum. It is used in combination with other medications to slow or stop cancer cell growth
-
Oxoplan may also be used to treat other types of cancer (such as) testicular cancer.
Packages
-
Oxoplan (Lyophilized) supplied as 50 mg/25 ml single vial per Boxe
-
Oxoplan (Lyophilized) supplied as 100 mg/50 ml single vial per Boxe
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Degarelix For Injection(Samgalix) 80 MG
₹ 2,890/VialGet Latest Price
| Dosage Strength | 80 mg |
| Strength | 80 mg |
| Brand | SEGARELIX |
| Treatment | Prostate Cancer |
| Usage/Application | Hospital |
| Manufacturer | Samarth |
| Storage Condition | 2-8 degree c |
| Form | Injection |
| Shelf Life | 18 month |
| Compostion | Degarelix |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
Product Name: Degarelix For Injection 80 MG
Brand Name: Samgalix
Strength: 80 MG
Packing: Single Vial Per Box
- Active Ingredient: Degarelix
- Strength: 80 mg per vial
- Form: Powder for injection, to be reconstituted with sterile water before use
- Administration Route: Subcutaneous (SC) injection
- Indication: Treatment of advanced prostate cancer
- Mechanism of Action: Gonadotropin-releasing hormone (GnRH) antagonist; reduces testosterone production by directly inhibiting GnRH receptors in the pituitary gland
- Dosage: Initial dose followed by maintenance doses; typically, the starting dose is higher, followed by 80 mg maintenance doses monthly
- Side Effects: Injection site reactions (pain, redness, swelling), hot flashes, increased liver enzymes, weight gain, fatigue
- Contraindications: Known hypersensitivity to degarelix or any of its components
- Precautions: Monitor liver function, cardiovascular status, and electrolyte levels during treatment
- Storage: Store vials in a refrigerator (2-8°C); reconstituted solution should be used immediately
Additional Information:
- Packaging Details: A Single Vial Per Box
View Complete Details
Megestrol Acetate Oral Suspension (Endace OS)40 Mg/Ml
₹ 5,350/BottleGet Latest Price
Minimum Order Quantity: 100 Bottle
| Strength | 40 mg |
| Pack Type | Box |
| Brand Name | ENDACE OS 240 ML |
| Manufacturer | Samarth Life Science Pvt. Ltd |
| Country of Origin | Made in India |
Product Name: Megestrol Acetate Oral Suspension USP 40mg/ml
Brand Name: ENDACE OS
Strength:40 mg/ml 240 ml
Packing: Single Bottle Per Box
Mechanism of Action
Megestrol acetate is a synthetic progestin; the exact mechanism through which it stimulates appetite and promotes weight gain (especially in conditions like cachexia or anorexia) remains not fully understood but is thought to involve hormonal modulation.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE BOTTLE PER BOX
View Complete Details
Megestrol Acetate Oral Suspension (Endace OS) 40 MG/ML
₹ 2,564/StripGet Latest Price
Minimum Order Quantity: 100 Strip
| Strength | 40 mg |
| Pack Type | Box |
| Brand Name | ENDACE OS 120 ML |
| Manufacturer | Samarth Life Science Pvt. Ltd |
| Country of Origin | Made in India |
Product Name: Megestrol Acetate Oral Suspension USP
Brand Name: ENDACE OS
Strength:40 mg/ml
Packing: Single Bottle Per Box
Mechanism of Action:
Megestrol acetate is a synthetic progestin; the exact mechanism through which it stimulates appetite and promotes weight gain (especially in conditions like cachexia or anorexia) remains not fully understood but is thought to involve hormonal modulation.
Indications:
Approved for anorexia, cachexia, or significant, unexplained weight loss associated with Acquired Immunodeficiency Syndrome (AIDS).
Often used off-label for appetite stimulation and weight gain in patients with advanced cancers, such as breast or endometrial carcinoma.
Recommended Adult Dose: 800 mg/day (equivalent to 20 mL/day) taken orally in a single daily dose or divided dosing, as directed.
Administration Instructions: Shake the bottle well before measuring dose. Use the provided measuring device—never a kitchen spoon. You may take it with or without food
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE BOTTLE PER BOX
View Complete Details
Oxaliplatin For Injection( Oxoplan-100) 100 MG
₹ 101/VialGet Latest Price
Minimum Order Quantity: 100 Vial
| Strength | 100 mg |
| Dose/Strength | 100 mg/ 20 ml |
| Vial Volume | 10 ml |
| Company | Samarth Life Science Pvt Ltd |
| Form | Lyophilized |
| Packaging Type | Vial |
| Shelf Life | 24 months |
| Manufacturer | Samarth Life Science Pvt. Ltd |
| Brand Name | Oxoplan-100 |
| Packing | Single Vial Per Box |
Product Name: Oxaliplatin Injection 100 MG
Brand Name: Oxoplan-100
Strength: 100 MG
Packing: Single Vial Per Box
-
Description:
- Methotrexate is a chemotherapy medication and immunosuppressant.
- These tablets contain 2.5 mg of methotrexate.
- They are intended for oral administration.
-
Mechanism of Action:
- Works by inhibiting dihydrofolate reductase, interfering with DNA synthesis and cell proliferation.
-
Indications:
- Used to treat various cancers, including leukemia, lymphoma, and breast cancer.
- Also prescribed for autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
-
Administration:
- Taken orally once a week or as directed by a healthcare provider.
- Dosage and duration depend on the condition being treated and patient response.
-
Adverse Reactions:
- Common side effects include nausea, vomiting, diarrhea, and mouth sores.
- May also cause bone marrow suppression, liver toxicity, and lung problems.
-
Contraindications:
- Hypersensitivity to methotrexate or related components.
- Pregnancy or breastfeeding due to potential harm to the fetus or infant.
-
Precautions:
- Monitor blood cell counts, liver function, and lung function regularly during treatment.
- Use caution in patients with liver or kidney disease, alcoholism, or infections.
-
Drug Interactions:
- May interact with medications affecting renal function, bone marrow, or liver metabolism.
- Inform healthcare providers about all concurrent medications.
-
Storage:
- Store at room temperature (15-30°C) away from moisture and sunlight.
-
Availability:
- Methotrexate tablets 2.5 mg are available in blister packs or bottles.
-
Monitoring and Follow-Up:
- Regular monitoring for treatment response, disease progression, and adverse reactions is essential.
- Adjust dosage or treatment schedule as needed based on patient's condition and tolerance.
-
Emergency Management:
- Promptly manage potential adverse effects like bone marrow suppression or liver toxicity.
- Healthcare providers should be trained in managing complications associated with methotrexate therapy.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: SINGLE VIAL PER BOX
View Complete Details
Degarelix For Injection (Samgalix) 120 MG
₹ 2,654/PieceGet Latest Price
| Dosage Strength | 120 mg |
| Strength | 120 mg |
| Brand | SEGARELIX |
| Treatment | Prostate Cancer |
| Manufacturer | Samarth |
| Storage Condition | 2-8 degree c |
| Shelf Life | 18 month |
| Country of Origin | Made in India |
| Brand Name | Samgalix |
| Packing | Single Vial Per Box |
| Manufactured By | Samarth |
Product Name: Degarelix For Injection 80 MG
Brand Name: Samgalix
Strength: 120 MG
Packing: Single Vial Per Box
- Active Ingredient: Degarelix
- Strength: 120 mg per vial
- Form: Powder for injection, to be reconstituted with sterile water before use
- Administration Route: Subcutaneous (SC) injection
- Indication: Treatment of advanced prostate cancer
- Mechanism of Action: Gonadotropin-releasing hormone (GnRH) antagonist; reduces testosterone production by directly inhibiting GnRH receptors in the pituitary gland
- Dosage: Initial dose followed by maintenance doses; typically, the starting dose is higher, followed by 80 mg maintenance doses monthly
- Side Effects: Injection site reactions (pain, redness, swelling), hot flashes, increased liver enzymes, weight gain, fatigue
- Contraindications: Known hypersensitivity to degarelix or any of its components
- Precautions: Monitor liver function, cardiovascular status, and electrolyte levels during treatment
- Storage: Store vials in a refrigerator (2-8°C); reconstituted solution should be used immediately
Additional Information:
- Packaging Details: A Single Vial Per Box
View Complete Details
| Strength | 15mg |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| Storage | Store below 25 DegreeC. |
Product Name: Thiotepa For Injection
Brand Name: Samtepa
Strength: 15 MG
Packing: A Single Vial Per Box
DescriptionThiotepa is a polyfunctional alkylating agent belonging to the ethylenimine class. It exhibits potent antineoplastic activity by interfering with the replication of DNA in rapidly dividing cells. Samtepa 15 mg is supplied as a sterile, white to off-white lyophilized powder for reconstitution before administration.Composition
Active Ingredient: Thiotepa – 15 mg
Excipients: May include mannitol and other stabilizers (as per approved formulation).
Indications
Samtepa (Thiotepa) 15 mg is indicated for:
-
Breast carcinoma – palliative treatment in advanced stages.
-
Ovarian carcinoma – recurrent or metastatic disease.
-
Superficial papillary carcinoma of the bladder – intravesical use to prevent recurrence.
-
Malignant effusions (pleural, peritoneal, pericardial) – via intracavitary administration.
-
Part of conditioning regimens in certain hematopoietic stem cell transplant protocols.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: A Single Vial Per Box
View Complete Details
| Strength | 100mg |
| Packaging Type | Vial |
| Country of Origin | Made in India |
Product Name: Thiotepa For Injection
Brand Name: Samtepa
Strength: 100 MG
Packing: Single Vial Per Box
DescriptionThiotepa is a polyfunctional alkylating agent belonging to the ethylenimine class of cytotoxic drugs.It appears as a white to off-white lyophilized powder that is reconstituted before administration.Indications
Thiotepa is indicated for the treatment of:
Breast Cancer – As palliative treatment in advanced stages.Ovarian Cancer – For patients with recurrent disease.
Superficial Papillary Bladder Carcinoma – Intravesical instillation to prevent recurrence.
Conditioning Regimen Prior to Hematopoietic Stem Cell Transplantation (HSCT) – In combination with other agents.
Other solid tumors or hematologic malignancies as per specialist discretion.
Storage
Store below 25°C in original vial, protected from light.
After reconstitution, store as per manufacturer’s stability data and use promptly.
Additional Information:
- Production Capacity: 1000
- Delivery Time: 4-5 weeks
- Packaging Details: Single Vial Per Box
View Complete Details
Explore more categories
need
details





































































































